Changing seroprevalence of hepatitis B virus markers of adults in Singapore

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 8, 2010, Pages 591-598

  Hong, Wei Wei ^a   Ang, Li Wei ^a   Cutter, Jeffrey L ^a   James, Lyn ^a   Chew, Suok Kai ^a   Goh, Kee Tai ^a  

^a MINISTRY OF HEALTH   (Singapore)

Author keywords

Adult infection; Catch up immunisation; Epidemiological trends

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINESE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEX DIFFERENCE; SINGAPORE; TREND STUDY; VIRUS IMMUNITY;

EID: 77957366921     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Goh KT. Epidemiology and Control of Hepatitis B Virus infection in Singapore. Tokyo: Southeast Asian Medical Information Center, 1992.
2. Goh KT, Doraisingham S, Tan KL, Oon CJ, Ho ML, Chen AJ, et al. The hepatitis B immunization programme in Singapore. Bull World Health Organ 1989;67:65-70.
3. Ministry of Health. Communicable Diseases Surveillance in Singapore 2007.
4. Committee on Epidemic Diseases. Prevalence of hepatitis B virus markers in Singapore. Epidemiol News Bull 2000;26:1-2.
5. Goh KT. Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore 1997;26:671-81.
6. Committee on Epidemic Diseases. Serological survey on hepatitis B virus infection in school children in Singapore. Epidemiol News Bull 1996;22:57-9.
7. Ong SC, Lim SG, Li SC. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore. Viral Hepat 2009;16:53-63.
8. James L, Fong CW, Foong BH, Wee MK, Chow A, Shum E, et al. Hepatitis B seroprevalence study 1999. Singapore Med J. 2001;42:420-4.
9. Ministry of Health Singapore. National Health Survey 2004. Available at: http://www.moh.gov.sg/mohcorp/publicationsreports.aspx?id=2984. Accessed 12 October 2009.
10. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford: Blackwell Scientific, 1987.
11. Ng HW. Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders. Ann Aca Med Singapore 1984;13:524-6.
12. Phoon WO, Fong HP. Lee J, Leong HK. A study on the prevalence of hepatitis B surface antigen among Chinese adult males in Singapore. Int J Epidemiol 1987;16:74-8.
13. Goh KT, Chan YW, Wong LYM, Kong KH, Oon CJ, Guan R. The prevalence of hepatitis B virus markers in dental personnel in Singapore. Trans R Soc Trop Med Hyg 1988;82:908-10.
14. Goh CL, Rajan VS, Chan SH, Kamarudin A. Hepatitis B infection in prostitutes. Int J Epidemiol 1986;15:112-5.
15. Goh CL, Kamarudin A, Chan SH, Rajan VS. Heaptitis B virus markers in prostitutes in Singapore. Genitourin Med 1985;61:127-9.
16. Ong YW. Some clinical and epidemiological aspects of HBsAg antigenaemia and alpha-feto protein levels in Singapore. In: Liver Cancer and Cancer Problems in Asian Countries. Proceedings of the AFOCC 2nd Asian Cancer Conference, Singapore, 1976:57-60.
17. Chan SH. Hepatitis B infection in Singapore. Epidemiol News Bull 1977;3:15-6.
18. Committee on Epidemic Diseases. A review of viral hepatitis B surveillance in Singapore, 1999-2004. Epidemiol News Bull 2005;31:27-31.
19. World Health Organization. Diseases Covered by EPR. Hepaitis B. Available at: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index1.html. Accessed 4 December 2009.
20. World Health Organization. Position paper on hepatitis B vaccines. Weekly Epidemiol Rec 2009;84:405-20.
21. Rani M, Yang B, Nesbit R. Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications. Bull World Health Organ 2009;87:707-13.
22. Yap EH, Ong YW, Simons MJ, Okochi K, Mayumi M. Australia antigen in Singapore II: differential frequency in Chinese, Malays and Indians. Vox Sang 1972;22:371-5.
23. Simons MJ, Yu M, Shanmugaratnam K. Hepatitis B antigenaemia, specific immune deficiency and hepatocellular carcinoma. Tumour Res 1973;8:120-6.
24. Centers for Disease Control and Prevention. Hepatitis B. In Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th ed, 2nd printing. Washington DC: Public Health Foundation, 2008.
25. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunisation of infants, children and adolescents. MMWR Recomm Rep 2005;54(RR-16):1-31.
26. Chan SH, Tan KL, Goh KT, Lim C, Tsakok M, Oon CL, et al. Maternalchild hepatitis B virus transmission in Singapore. Int J Epidemiol 1985;14:173-7.
27. Committee on Epidemic Diseases. Prevention and control of hepatitis B virus infection in Singapore. Epidemiol News Bull 2002;28:31-4.
28. Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K. Trends in cancer incidence in Singapore 1968-2002. Singapore Cancer Registry Report No. 6, 2004.
29. Goh KT, Tan KL, Kong KH, Oon CJ, Chan SH. Comparision of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore: a four-year follow-up study. Bull World Health Organ 1992;70:233-9.
30. Goh KT, Oon CJ, Heng BH, Lim GK. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull World Health Organ 1995;73:523-7.
31. Chen Y, Wu W, Li LJ, Lou B, Zhang J, Fan J. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta 2006;372:129-33. Epub 2006 May 19.
32. Heng BH, Goh KT, Chan R, Chew SK, Doraisingham S, Quek GH. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with HBV intermediate endemicity. J Epidemiol Community Health 1995;49:309-13.